Health Condition 1: O- Medical and Surgical Health Condition 2: M20-M25- Other joint disorders
Conditions
Interventions
Intervention1: Dexmedetomedine: 1 mcg/kg of Dexmedetomidine along with 20 ml of Ropivacaine 0.2% for a period of 2 year .
Control Intervention1: Clonidine: 2 mcg/kg of Clonidine in addition to 20 ml o
Sponsors
Datta Meghe Institute of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: 1.Individuals between the ages of 18 and 60 years. 2.patients scheduled for elective spine surgery like laminectomies, discectomies, spinal fusions, and other spinal operations. 3.Patients with physical status classes I through II according to the American Society of Anesthesiologists (ASA). 4.Patients who are capable of giving their informed consent to take part in the trial.
Exclusion criteria
Exclusion criteria: 1.Patients in whom epidural anaesthesia is contraindicated. 2.Patients having established allergies to any of the research medications . 3.Patients who have had opioid dependency or persistent pain in the past. 4.Pregnant or lactating females. 5.Patients with spinal cord injuries or neurological deficiencies. 5.Patients with a background of severe renal, hepatic, or cardiovascular illness. 6.Patients who are unable to assist with data collection or pain assessment (for example, because of cognitive disability).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Score (VAS) Duration of Analgesia Vital Parameters Adverse effects if anyTimepoint: Pain Score (VAS) Duration of Analgesia Vital Parameters Adverse effects if any for period of 48 hours . | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Dhawal Rameshpant Wadaskar
Datta Meghe Institute of Higher Education and Research
Outcome results
None listed